SCM
MRNA icon

Sandler Capital Management’s Moderna MRNA Stock Holding History

Sandler Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,010
Closed -$8.46M – 119
2021
Q2 		$8.46M Buy
+36,010
New +$6.44M 0.66% 58

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Sandler Capital Management's MRNA Position: Q3 2021 in Review

Sandler Capital Management sold out of Moderna (MRNA) in Q3 2021, closing a stake of 36,010 shares — an estimated $8.46M sold.

Sandler Capital Management first reported a position in MRNA in Q2 2021 and held it in 1 quarter. The position peaked at $8.46M in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Sandler Capital Management reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • Sandler Capital Management sold 36,010 Moderna shares in Q3 2021, an estimated $8.46M.
  • Sandler Capital Management first reported a position in Moderna in Q2 2021 and held it in 1 quarter.
  • Sandler Capital Management's Moderna position peaked at $8.46M in Q2 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Sandler Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.